Sign In
Buy FIXX
$0.93
+0 (+0%)
At Close: Jun 24, 2024
Homology Medicines (FIXX) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Monday, 10'th Aug 2020
Homology Medicines (FIXX) delivered earnings and revenue surprises of 3.70% and 20.64%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Homology Medicines Reports Second Quarter 2020 Financial Results and Provides Business Update
08:05pm, Monday, 10'th Aug 2020
Three Cohorts Enrolled in Phase 1/2 pheNIX Gene Therapy Trial for PKU Progressed Into Later Stages of IND-Enabling Studies for MLD Gene Therapy and PKU Gene Editing Programs and Published Key DataSuc
We're Keeping An Eye On Homology Medicines' (NASDAQ:FIXX) Cash Burn Rate
04:39pm, Monday, 10'th Aug 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Here's Why We're Watching Homology Medicines' (NASDAQ:FIXX) Cash Burn Situation
04:38pm, Monday, 10'th Aug 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Earnings Preview: Homology Medicines (FIXX) Q2 Earnings Expected to Decline
04:30pm, Thursday, 06'th Aug 2020
Homology Medicines (FIXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Homology Medicines (NASDAQ:FIXX) Stock Rating Upgraded by Zacks Investment Research
01:46am, Wednesday, 05'th Aug 2020
Homology Medicines (NASDAQ:FIXX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Monday, Zacks.com reports. According to Zack
3 “Strong Buy” Pharma Stocks With Fast-Approaching Catalysts
03:42am, Tuesday, 28'th Jul 2020
Given the widespread market volatility, some investors are seeking refuge in more defensible stocks. However, this certainly doesn’t apply to every Wall Street observer. A select group remains ready
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
Homology Medicines Appoints Jeff Poulton to the Board of Directors
12:00pm, Tuesday, 21'st Jul 2020
\- Executive with Extensive Rare Disease Expertise in Global Finance and Commercial Operations - BEDFORD, Mass., July 21, 2020 -- Homology Medicines, Inc. (Nasdaq: FIXX), a.
Homology Medicines (FIXX) Looks Good: Stock Adds 8% in Session
12:49pm, Wednesday, 08'th Jul 2020
Homology Medicines (FIXX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Biogen and Southwest Are on the Casualty List
02:49pm, Monday, 29'th Jun 2020
In a climate of rampant uncertainty, what should an investor do? Continue reading...
Homology Medicines, Inc. (FIXX): Hedge Funds Are Snapping Up
06:58pm, Saturday, 27'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Canaccord Genuity Sticks to Its Buy Rating for Stoke Therapeutics (STOK) - Markets
10:08am, Friday, 26'th Jun 2020
Canaccord Genuity analyst Michelle Gilson reiterated a Buy rating on Stoke Therapeutics (STOK – Research Report) today and set a
Cowen & Co. Maintains a Buy Rating on IVERIC bio (ISEE) - Markets
12:47pm, Wednesday, 17'th Jun 2020
Cowen & Co. analyst Ken Cacciatore maintained a Buy rating on IVERIC bio (ISEE – Research Report) on June 15
